What does the evidence say about Iron Bisglycinate Fatigue Randomized Trial?

The current Migaku evidence database contains 1 reusable source document for Iron Bisglycinate Fatigue Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - In a prospective cross-over stable-isotope absorption trial in young iron-deficient women (n = 52), OatNF reduced with sodium ascorbate carried mainly ferrous iron and showed high fractional absorption with water and with polyphenol-rich food, showing 1.76- and 1.65-fold higher absorption, respectively, compared with ferrous sulfate. [Zhou J (2025); evidence level 4] - Iron fortification can help to treat anaemia, but most current fortificants are limited by low absorption and/or poor sensory properties. [Zhou J (2025); evidence level 4] - Here we introduce oat protein nanofibrils (OatNF) carrying ultrasmall iron nanoparticles that are engineered to carry iron in ferrous or ferric form. [Zhou J (2025); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.